Literature DB >> 21343148

Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer.

Philip E Castle1, Ana Cecilia Rodríguez, Robert D Burk, Rolando Herrero, Sholom Wacholder, Allan Hildesheim, Jorge Morales, Greg Rydzak, Mark Schiffman.   

Abstract

BACKGROUND: Detailed descriptions of long-term persistence of human papillomavirus (HPV) in the absence of cervical precancer are lacking.
METHODS: In a large, population-based natural study conducted in Guanacaste, Costa Rica, we studied a subset of 810 initially HPV-positive women with ≥ 3 years of active follow-up with ≥ 3 screening visits who had no future evidence of cervical precancer. Cervical specimens were tested for >40 HPV genotypes using a MY09/11 L1-targeted polymerase chain reaction method.
RESULTS: Seventy-two prevalently-detected HPV infections (5%) in 58 women (7%) persisted until the end of the follow-up period (median duration of follow-up, 7 years) without evidence of cervical precancer. At enrollment, women with long-term persistence were more likely to have multiple prevalently-detected HPV infections (P < .001) than were women who cleared their baseline HPV infections during follow-up. In a logistic regression model, women with long-term persistence were more likely than women who cleared infections to have another newly-detected HPV infection detectable at ≥ 3 visits (odds ratio, 2.6; 95% confidence interval, 1.2-5.6).
CONCLUSIONS: Women with long-term persistence of HPV infection appear to be generally more susceptible to other HPV infections, especially longer-lasting infections, than are women who cleared their HPV infections.

Entities:  

Mesh:

Year:  2011        PMID: 21343148      PMCID: PMC3071125          DOI: 10.1093/infdis/jiq116

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Persistent minor smear abnormalities: is large loop excision of the transformation zone (LLETZ) the solution?

Authors:  N Pisal; M Sindos; M E Mansell; Theresa Freeman-Wang; A Singer
Journal:  J Obstet Gynaecol       Date:  2003-09       Impact factor: 1.246

2.  Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse.

Authors:  Robert G Pretorius; Wen-Hua Zhang; Jerome L Belinson; Man-Ni Huang; Ling-Ying Wu; Xun Zhang; You-Lin Qiao
Journal:  Am J Obstet Gynecol       Date:  2004-08       Impact factor: 8.661

3.  Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments.

Authors:  Hans-Ulrich Bernard; Robert D Burk; Zigui Chen; Koenraad van Doorslaer; Harald zur Hausen; Ethel-Michele de Villiers
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

4.  Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project.

Authors:  R Herrero; M H Schiffman; C Bratti; A Hildesheim; I Balmaceda; M E Sherman; M Greenberg; F Cárdenas; V Gómez; K Helgesen; J Morales; M Hutchinson; L Mango; M Alfaro; N W Potischman; S Wacholder; C Swanson; L A Brinton
Journal:  Rev Panam Salud Publica       Date:  1997-05

Review 5.  Natural history of cervical intraepithelial neoplasia: a critical review.

Authors:  A G Ostör
Journal:  Int J Gynecol Pathol       Date:  1993-04       Impact factor: 2.762

6.  Comparisons of HPV DNA detection by MY09/11 PCR methods.

Authors:  Philip E Castle; Mark Schiffman; Patti E Gravitt; Hortense Kendall; Stacy Fishman; Huali Dong; Allan Hildesheim; Rolando Herrero; M Concepcion Bratti; Mark E Sherman; Attila Lorincz; John E Schussler; Robert D Burk
Journal:  J Med Virol       Date:  2002-11       Impact factor: 2.327

7.  The natural history of type-specific human papillomavirus infections in female university students.

Authors:  Harriet Richardson; Gail Kelsall; Pierre Tellier; Hélène Voyer; Michal Abrahamowicz; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-06       Impact factor: 4.254

8.  Behavior of moderate cervical dysplasia during long-term follow-up.

Authors:  K Nasiell; M Nasiell; V Vaćlavinková
Journal:  Obstet Gynecol       Date:  1983-05       Impact factor: 7.661

9.  Behavior of mild cervical dysplasia during long-term follow-up.

Authors:  K Nasiell; V Roger; M Nasiell
Journal:  Obstet Gynecol       Date:  1986-05       Impact factor: 7.661

10.  Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.

Authors:  M Concepción Bratti; Ana C Rodríguez; Mark Schiffman; Allan Hildesheim; Jorge Morales; Mario Alfaro; Diego Guillén; Martha Hutchinson; Mark E Sherman; Claire Eklund; John Schussler; Julie Buckland; Lidia A Morera; Fernando Cárdenas; Manuel Barrantes; Elmer Pérez; Thomas J Cox; Robert D Burk; Rolando Herrero
Journal:  Rev Panam Salud Publica       Date:  2004-02
View more
  20 in total

1.  Factors affecting linkage to care and engagement in care for newly diagnosed HIV-positive adolescents within fifteen adolescent medicine clinics in the United States.

Authors:  Morgan M Philbin; Amanda E Tanner; Anna DuVal; Jonathan M Ellen; Jiahong Xu; Bill Kapogiannis; Jim Bethel; J Dennis Fortenberry
Journal:  AIDS Behav       Date:  2014-08

Review 2.  Advances in technologies for cervical cancer detection in low-resource settings.

Authors:  Kathryn A Kundrod; Chelsey A Smith; Brady Hunt; Richard A Schwarz; Kathleen Schmeler; Rebecca Richards-Kortum
Journal:  Expert Rev Mol Diagn       Date:  2019-08-01       Impact factor: 5.225

3.  ERAP1 overexpression in HPV-induced malignancies: A possible novel immune evasion mechanism.

Authors:  Alina Steinbach; Jan Winter; Miriam Reuschenbach; Renata Blatnik; Alexandra Klevenz; Miriam Bertrand; Stephanie Hoppe; Magnus von Knebel Doeberitz; Agnieszka K Grabowska; Angelika B Riemer
Journal:  Oncoimmunology       Date:  2017-06-20       Impact factor: 8.110

4.  Understanding Care Linkage and Engagement Across 15 Adolescent Clinics: Provider Perspectives and Implications for Newly HIV-Infected Youth.

Authors:  Morgan M Philbin; Amanda E Tanner; Anna DuVal; Jonathan M Ellen; Bill Kapogiannis; J Dennis Fortenberry
Journal:  AIDS Educ Prev       Date:  2017-04

5.  What affects timely linkage to HIV Care for Young Men of Color who have sex with Men? Young Men's Experiences Accessing HIV Care after Seroconverting.

Authors:  Jeremy T Goldbach; Michele D Kipke
Journal:  AIDS Behav       Date:  2022-06-07

6.  Key considerations and current perspectives of epidemiological studies on human papillomavirus persistence, the intermediate phenotype to cervical cancer.

Authors:  S L Sudenga; S Shrestha
Journal:  Int J Infect Dis       Date:  2013-02-27       Impact factor: 3.623

7.  Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings.

Authors:  Anja Oštrbenk Valenčak; Anja Šterbenc; Katja Seme; Mario Poljak
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

Review 8.  Updating the natural history of human papillomavirus and anogenital cancers.

Authors:  Anna-Barbara Moscicki; Mark Schiffman; Ann Burchell; Ginesa Albero; Anna R Giuliano; Marc T Goodman; Susanne K Kjaer; Joel Palefsky
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

Review 9.  The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.

Authors:  Jayshree R S
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

10.  Research of the potential biomarkers in vaginal microbiome for persistent high-risk human papillomavirus infection.

Authors:  Xiaopei Chao; Tingting Sun; Shu Wang; Xianjie Tan; Qingbo Fan; Honghui Shi; Lan Zhu; Jinghe Lang
Journal:  Ann Transl Med       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.